Distinguishing Non-Small Cell Lung Adenocarcinoma Patients from Squamous Cell Carcinoma Patients and Control Individuals Using Serum Profiling

被引：6
|
作者：
Hocker, James R. [1 ]
Peyton, Marvin D. [2 ]
Lerner, Megan R. [2 ,3 ]
Lightfoot, Stan A. [3 ,4 ]
Hanas, Rushie J. [1 ]
Brackett, Daniel J. [2 ,3 ]
Hanas, Jay S. [1 ,2 ,3 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK 73104 USA
[3] Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA
[4] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
来源：
CANCER INVESTIGATION | 2012年 / 30卷 / 02期
关键词：
Non-small cell lung cancer; Adenocarcinoma; Squamous cell carcinoma; Serum profiling; Early detection; Predictive value analysis; Electrospray mass spectrometry; OVARIAN-CANCER; IDENTIFICATION; SPECTROMETRY; BIOMARKERS; PROTEOMICS; DISCOVERY;
D O I：
10.3109/07357907.2011.633294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were obtained from 19 adenocarcinoma patients, 24 squamous cell carcinoma patients, and 21 controls. Identifications of significant mass-to-charge ratio (m/z) peak differences between these groups were performed using t-tests. A "leave one out" cross-validation procedure yielded discriminatory lung adenocarcinoma versus squamous cell carcinoma p and ROC curve values of < .0001 and 0.92, respectively. Test sensitivity and specificity were 84% and 79%, respectively. This approach could aid in lung cancer diagnosis and sub-typing.
引用
收藏
页码：180 / 188
页数：9
相关论文
共 50 条
  • [31] From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma
    Ileana, Ecaterina E.
    Wistuba, Ignacio I.
    Izzo, Julie G.
    CANCER JOURNAL, 2015, 21 (05) : 413 - 424
  • [32] Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients
    Gezici, Sevgi
    Ozaslan, Mehmet
    Akpinar, Gurler
    Kasap, Murat
    Sanli, Maruf
    Elbeyli, Levent
    CURRENT PROTEOMICS, 2017, 14 (01) : 58 - 77
  • [33] A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer
    Katsunori Kagohashi
    Hiroaki Satoh
    Hiroichi Ishikawa
    Morio Ohtsuka
    Kiyohisa Sekizawa
    Medical Oncology, 2008, 25 : 187 - 189
  • [34] The importance of serum total and lipid-bound sialic acid as markers in patients with small cell and non-small cell lung carcinoma
    Gokmen, Selma Suer
    Kazezoglu, Cemal
    Tabakoglu, Erhan
    Altiay, Guendeniz
    Gungoer, Ozgul
    Ture, Mevlut
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2007, 24 (02): : 101 - 108
  • [35] Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer
    Li, Piaopiao
    Kuang, Xuemei
    Zhang, Tingting
    Ma, Lei
    FRONTIERS IN SURGERY, 2022, 9
  • [36] Prognostic impact of serum transthyretin in patients with non-small cell lung cancer
    Shimura, Tatsuo
    Shibata, Masahiko
    Inoue, Takuya
    Owada-Ozaki, Yuki
    Yamaura, Takumi
    Muto, Satoshi
    Hasegawa, Takeo
    Shio, Yutaka
    Suzuki, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 597 - 604
  • [37] TRYPTOPHAN METABOLITES IN SERUM AND FECES OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Zlatnik, E. Yu
    Sagakyants, A. B.
    Shatova, O. P.
    Zabolotneva, A. A.
    Appolonova, S. A.
    Moskaleva, N. E.
    Meshkov, I. O.
    Rumyantsev, S. A.
    Shestopalov, A., V
    YAKUT MEDICAL JOURNAL, 2021, (04): : 89 - 92
  • [38] Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients
    Goebel, Cherylle
    Louden, Christopher L.
    Mckenna, Robert, Jr.
    Onugha, Osita
    Wachtel, Andrew
    Long, Thomas
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (04) : 229 - 244
  • [39] Differences in patterns of recurrence of squamous cell carcinoma and adenocarcinoma after radiotherapy for stage III non-small cell lung cancer
    Katagiri, Yu
    Jingu, Keiichi
    Yamamoto, Takaya
    Matsushita, Haruo
    Umezawa, Rei
    Ishikawa, Yojiro
    Takahashi, Noriyoshi
    Takeda, Kazuya
    Tasaka, Shun
    Kadoya, Noriyuki
    JAPANESE JOURNAL OF RADIOLOGY, 2021, 39 (06) : 611 - 617
  • [40] A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer
    Kagohashi, Katsunori
    Satoh, Hiroaki
    Ishikawa, Hiroichi
    Ohtsuka, Morio
    Sekizawa, Kiyohisa
    MEDICAL ONCOLOGY, 2008, 25 (02) : 187 - 189
12345